DNA Test Completed October 09, 2012

Registered Name: Stirling's Serenading Seraph
Call Name: Angel

Breed: Collie
Gender: Female

Optigen Accession #: 12-8284


Test Performed: Rod-Cone Dysplasia Type 2

Sample Type: Swab

Test Results: Genotype of Dog tested is Normal

Risk for developing rcd2 form of PRA: Will never develop rcd2 form of PRA.

Significance for breeding: Can be bred to any dog and will produce no pups affected by rcd2 form of PRA.

This interpretation is based on the test result of the DNA test for the specific mutation identified as causing the rcd2 form of PRA in Collies as of the date on this report.

For further information, please visit OptiGen's website at www.optigen.com.
 

DNA Test Completed October 04, 2012

Registered Name: Stirling's Serenading Seraph
Call Name: Angel

Breed: Collie
Gender: Female

Optigen Accession #: 12-8284


Test Performed: CEA/CH test

Sample Type: Swab

Test Results: Genotype of your dog is NORMAL/CLEAR.
Risk for developing Collie Eye Anomaly/Choroidal Hypoplasia (CEA/CH): This dog will never develop CEA/CH.
Significance for breeding: This dog can be bred to any mate and will produce no pups affected with CEA/CH.

This interpretation is based on the test result of the DNA test for the specific mutation identified as causing CEA/CH in Collies as of the date on this report.


For further information, please consult the OptiGen website at www.optigen.com.